Neuss (ots) - In der kommenden Legislaturperiode - somit ab 2018 - soll das E-Health-Gesetz um einen zweiten ...
Sanofi Pasteur and Merck Vaccines Appoint David Khougazian as President of Sanofi Pasteur MSD
Lyon, France (ots/PRNewswire) - MSD, known as Merck in the United States and Canada and Sanofi Pasteur, the vaccines division of Sanofi , the two partner companies in Sanofi Pasteur MSD, announce today the appointment of David Khougazian as president of Sanofi Pasteur MSD.
To view the Multimedia News Release, please click: http://www.multivu.com/players/uk/7563651-david-khougazian-president-sanofi-pasteur/ [http://www.multivu.com/players/uk/7563651-david-khougazian-president-sanofi-pasteur]
On July 1, Khougazian will join Sanofi Pasteur MSD and effective September 1, will succeed Dr. Jean-Paul Kress, who led the company since July 2011. Kress will leave Sanofi Pasteur MSD to join the Sanofi group.